TRUFILL n-BCA Liquid Embolic System is a safe, proven and effective treatment of Arterio-Venous Malformations (AVMs). Since 2000, over 15,000 patients have been treated with the TRUFILL n-BCA Liquid Embolic System

The TRUFILL n-BCA Liquid Embolic System offers:

• Low Procedure Time
• Low Fluoroscopy Time
• Low Re-canalization Rates
• Effective Penetration of AVM

 
During its clinical trial, the TRUFILL n-BCA Liquid Embolic System was found to have equivalency in safety and efficacy compared with PVA embolization particles in achieving vascular occlusion.
The TRUFILL n-BCA Liquid Embolic System is fully compatable with the full line of PROWLER®, TRANSIT® & RAPIDTRANSIT® Microcatheters.

Full description and source